An apparent explanation as to why higher VDR levels predict better prognosis in patients treated with TAM is that VitD sensitizes breast cancer cells to antiestrogen therapy [58,59,60,61,62,63,64], as also found in the present study. Here, VDR is linked to breast carcinoma.